Proto Labs (NYSE:PRLB) Issues Q4 2025 Earnings Guidance

Proto Labs (NYSE:PRLB) updated its fourth quarter 2025 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of 0.300-0.380 for the period, compared to the consensus estimate of 0.280. The company issued revenue guidance of $125.0 million-$133.0 million, compared to the consensus revenue estimate of $129.2 million.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on PRLB. Craig Hallum raised shares of Proto Labs from a “hold” rating to a “buy” rating and set a $54.00 target price for the company in a report on Friday, August 1st. Wall Street Zen raised Proto Labs from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 2nd. Weiss Ratings reissued a “hold (c-)” rating on shares of Proto Labs in a research note on Wednesday, October 8th. Finally, Cantor Fitzgerald raised their target price on shares of Proto Labs from $50.00 to $51.00 and gave the company an “overweight” rating in a report on Friday, August 1st. Two investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $52.50.

Proto Labs Trading Down 6.3%

Proto Labs stock opened at $49.69 on Friday. The stock has a fifty day moving average price of $50.88 and a 200 day moving average price of $43.81. Proto Labs has a 52 week low of $27.18 and a 52 week high of $55.90. The firm has a market capitalization of $1.19 billion, a P/E ratio of 82.82 and a beta of 1.24.

Proto Labs (NYSE:PRLB) last posted its quarterly earnings results on Friday, October 31st. The industrial products company reported $0.47 EPS for the quarter, beating the consensus estimate of $0.39 by $0.08. The company had revenue of $135.37 million during the quarter, compared to analysts’ expectations of $133.83 million. Proto Labs had a return on equity of 2.22% and a net margin of 2.91%.The firm’s revenue was up 8.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.47 EPS. Proto Labs has set its Q4 2025 guidance at 0.300-0.380 EPS. As a group, equities analysts predict that Proto Labs will post 0.81 EPS for the current year.

Insider Transactions at Proto Labs

In related news, CEO Suresh Krishna purchased 1,725 shares of the company’s stock in a transaction that occurred on Monday, August 4th. The stock was purchased at an average price of $43.51 per share, with a total value of $75,054.75. Following the completion of the transaction, the chief executive officer owned 18,021 shares of the company’s stock, valued at approximately $784,093.71. This trade represents a 10.59% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 1.70% of the company’s stock.

Institutional Trading of Proto Labs

Institutional investors and hedge funds have recently made changes to their positions in the company. Osaic Holdings Inc. raised its position in shares of Proto Labs by 477.4% in the 2nd quarter. Osaic Holdings Inc. now owns 3,072 shares of the industrial products company’s stock worth $123,000 after buying an additional 2,540 shares during the period. Nomura Holdings Inc. acquired a new stake in Proto Labs during the second quarter worth about $247,000. Public Sector Pension Investment Board raised its holdings in shares of Proto Labs by 4.3% in the 2nd quarter. Public Sector Pension Investment Board now owns 81,016 shares of the industrial products company’s stock worth $3,244,000 after purchasing an additional 3,337 shares during the period. CANADA LIFE ASSURANCE Co raised its holdings in shares of Proto Labs by 8.1% in the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 21,377 shares of the industrial products company’s stock worth $856,000 after purchasing an additional 1,606 shares during the period. Finally, Tower Research Capital LLC TRC grew its holdings in shares of Proto Labs by 363.0% during the 2nd quarter. Tower Research Capital LLC TRC now owns 2,806 shares of the industrial products company’s stock worth $112,000 after purchasing an additional 2,200 shares during the period. 84.54% of the stock is currently owned by institutional investors and hedge funds.

Proto Labs Company Profile

Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.